
Svizera Pharma Private Limited
About Svizera Pharma Private Limited
Data last updated:
Svizera Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 24 April 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2000PTC126087.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Maneesh Ramakant Sapte and Vinay Ramakant Sapte.
Its last annual general meeting (AGM) was held on 11 July 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot D – 16/6 Ttc Industrialestate MIDC Turbhe, Navi Mumbai, Maharashtra, India – 400703.
As per the financials filed for FY 2023, the company reported a revenue of ₹89,958. For the same year it recorded a net profit of ₹43,408 (net margin 48.3%) and EBITDA of ₹63,408 (EBITDA margin 70.5%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Svizera Pharma Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot D – 16/6 Ttc Industrialestate MIDC Turbhe, Navi Mumbai, Maharashtra, India – 400703
- IndustryFMCG, Personal Care & Skincare Products
To see the full contact details of Svizera Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Svizera Pharma Private Limited
FY 2023 filings availableSvizera Pharma Private Limited reported revenue of ₹89,958 for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over three years. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹89,958 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹63,408 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹43,408 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 70.5% | ||||
| Net Profit Margin | 48.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Svizera Pharma Private Limited, buy the company report.
Board of directors of Svizera Pharma Private Limited
Svizera Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maneesh Ramakant Sapte | Director | 24 Apr 2000 | 26 Years 6 Months | Current |
| Vinay Ramakant Sapte | Director | 24 Apr 2000 | 26 Years 6 Months | Current |
Auditor
Svizera Pharma Private Limited is audited by M. Nanday & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. Nanday & Co. | FY 2023 | 106864W |
Shareholding
The shareholding of Svizera Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Svizera Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Svizera Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Svizera Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Svizera Pharma has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Svizera Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Svizera Pharma Private Limited has 2 board changes on record since 2000: 2 appointments. The latest: Maneesh Ramakant Sapte was appointed as Director on 24 Apr 2000.
Frequently asked questions
Svizera Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 24 April 2000 (26+ years old) and is registered under CIN U24239MH2000PTC126087.
Svizera Pharma has 2 current directors:
- Maneesh Ramakant Sapte - Director
- Vinay Ramakant Sapte - Director
The latest financial statements of Svizera Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 11 July 2023. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Svizera Pharma is U24239MH2000PTC126087. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Svizera Pharma was incorporated on 24 April 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
Maneesh Ramakant Sapte was appointed as Director on 24 Apr 2000. Vinay Ramakant Sapte was appointed as Director on 24 Apr 2000.
The registered office of Svizera Pharma is at Plot D – 166 Ttc Industrialestate MIDC Turbhe, Navi Mumbai, Maharashtra, India – 400703.
Svizera Pharma operates in the FMCG industry, in the personal care and skincare products segment.
The compliance status of Svizera Pharma is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.
Svizera Pharma can be reached at its registered office: Plot D – 166 Ttc Industrialestate MIDC Turbhe, Navi Mumbai, Maharashtra, India – 400703.

